First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M. Liau, Santosh Kesari, Rekha Chaudhary et al.|Journal of Translational Medicine|2018Cited by 540
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent GlioblastomaLinda M. Liau, Lynne P. Taylor, Keyoumars Ashkan et al.|JAMA Oncology|2022Cited by 411
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade GliomaTimothy F. Cloughesy, Michael A. Vogelbaum, Kevin Petrecca et al.|JAMA Oncology|2020Cited by 144
Refractory epilepsy in tuberous sclerosis: Vagus nerve stimulation with or without subsequent resective surgeryRobert E. Elliott, Werner Doyle, Chad Carlson et al.|Epilepsy & Behavior|2009Cited by 74
Do tubers contain function? Resection of epileptogenic foci in perirolandic cortex in children with tuberous sclerosis complexYaron A. Moshel, Howard L. Weiner, Robert E. Elliott et al.|Epilepsia|2010Cited by 52